Home » Clinical Trials » Therapeutic Areas

Therapeutic Areas: Immunology | Pediatrics/Neonatology | Vaccines
Disease Category: Vaccines
Location: United States, UT

Clinical Trial Details

Overview

Research Study Summary

Clostridium difficle Vaccine (C. diff)

Purpose

Spending a Lot of Time at the Doctor?

Learn about a study of an investigational vaccine for people who may be at risk of Clostridium difficile (C. diff).

People who are taking antibiotics or are being treated at a hospital or health care facility have an increased chance of getting sick due to C. diff. C. diff can cause frequent diarrhea, abdominal pain, and inflammation of the colon which, when severe, can be life threatening.

  • Have you had at least 2 visits to the emergency room, or had a hospitalization of at least 2 nights in the last 12 months? or
  • Are a resident in a nursing facility? or
  • Do you have a planned surgery that will require a hospital stay of 2 nights or more?

    If you are at least 50 years of age and answered yes to any of the questions above, you may be eligible to participate in a study being done to evaluate the effectiveness of an investigational vaccine for reducing the chance of getting C. diff.

    To Learn more

    CW ID: 224188
    Date Last Changed: April 25, 2017

  • Clinical Trial Snapshot

    Phase
    3
    Gender
    Both Male and Female
    Age
    50 and up
    Overall Status
    Recruiting
    Facility Type
    Out-Patient

    Eligibility

    Do you suffer from 3 to 8 migraines per month? Were you diagnosed more than a year ago? Do you have cardiovascular risk factors, too? Then consider joining SPARTAN - a clinical study to assess a potential new migraine medication for people like you.

    Can I take part in this important study?

    We're looking for people over 18 years of age who experience 3 to 8 migraines per month to take part. We'd especially like to hear from migraine sufferers with at least one of the following cardiovascular risk factors (but ALL migraine sufferers are welcome to contact us):

    • High blood pressure
    • High cholesterol
    • A smoker
    • Overweight
    • Diabetes
    • Family history of coronary artery disease
    • Female and post-menopause
    • Male and over 40 years of age

    If you'd like to take part, we'll arrange a clinic visit to check that you and the study are a good fit.

    At this visit, we'll:
    • Ask you about your health
    • Check your heart
    • Take a blood sample
    • Collect a urine sample
    • Give you a dosing card containing tablets of either the study medication or an inactive placebo (at no cost)
    • Give you an electronic diary to record information about the migraine you treat with study drug along with migraine symptoms during your migraine

    Within one week of this visit, we'll contact you by telephone to tell you if you're suitable for the study. If you are, we'll ask you to treat your next migraine using the tablets provided and remind you how to use the diary. After this migraine (or 8 weeks later if you don't have one), you'll have a final check-up. That's 2 visits in total. Please note - you'll also need to have a second clinic visit if you're not suitable. This is so that you can return the tablets and diary.

    Contact

    J. Lewis Research, Inc.
    2295 Foothill Dr
    Salt Lake City, UT 84109
    Phone: 801-486-3021

    View Map

    Research Center Information:

    J. Lewis Research, Inc.

    Volunteer for this Trial

    If you would like to learn more about participating in this research study, please email the trial contact using the form below. We value your privacy and your information will only be used by the research center to contact you regarding this study.

    DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.